Artelo Biosciences (ARTL) announced that it has received a letter from Nasdaq confirming that the company has regained compliance with Nasdaq Listing Rule 5550, the “Equity Rule,” and Listing Rule 5620, the “Annual Shareholders Meeting Rule.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARTL:
- 3 Penny Stocks to Watch Now, 3/31/26
- Artelo Biosciences Soars 230% on Obesity Push — Why Is ARTL Stock Now Crashing?
- ARTL Upcoming Earnings Report: What to Expect?
- Artelo Biosciences announces $11M private placement priced at-the-market
- Artelo announces expansion opportunity for ART27.13 in muscle preservation